View Entire Collection
By Clinical Topic
By State Requirement
Diabetes – Summer 2012
Future of Nursing Initiative
Heart Failure - Fall 2011
Influenza - Winter 2011
Nursing Ethics - Fall 2011
Trauma - Fall 2010
Traumatic Brain Injury - Fall 2010
Fluids & Electrolytes
TUESDAY, Dec. 6 (HealthDay News) -- Companies that market over-the-counter products containing human chorionic gonadotropin (HCG) and labeled as "homeopathic" for weight loss are violating federal law and have been issued warnings, according to a Dec. 6 announcement from the U.S. Food and Drug Administration and the Federal Trade Commission (FTC).
HCG, which is FDA-approved for the treatment of some cases of female infertility and other medical conditions, has never been approved for weight loss. The companies that market such drugs for this off-label purpose have been issued Warning Letters by the FDA and FTC in a joint effort by the two agencies to keep unproven and possibly unsafe products off the market.
The companies have 15 days to notify the FDA of their progress toward correcting violations that include selling drugs for unapproved purposes and making unsubstantiated claims about their product.
"Deceptive advertising about weight loss products is one of the most prevalent types of fraud," David Vladeck, director of the FTC's Bureau of Consumer Protection, said in a statement. "Any advertiser who makes health claims about a product is required by federal law to back them up with competent and reliable scientific evidence, so consumers have the accurate information they need to make good decisions."
Sign up for our free enewsletters to stay up-to-date in your area of practice - or take a look at an archive of prior issues
Join our CESaver program to earn up to 100 contact hours for only $34.95
Explore a world of online resources
Back to Top